Physician profile
Erin Watson
NPI 1114139854
$9,110.42
in general payments reported to CMS, 2019-2025
42 companies · $1,355 in 2025
The $1,355 reported for 2025 was more than what 78% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,311 · 2020: $548 · 2021: $445 · 2022: $1,795 · 2023: $686 · 2024: $971 · 2025: $1,355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,012.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $2,440.57 | 2019-2024 | Senza |
| Boston Scientific Corporation | $1,557.73 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Medtronic, INC. | $1,524.86 | 2022-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Collegium Pharmaceutical, INC. | $545.17 | 2019-2025 | Xtampza, Belbuca |
| Radius Health, INC. | $403.98 | 2019-2025 | Tymlos |
| Nalu Medical, INC. | $268.65 | 2022-2025 | Nalu Neurostimulation System |
| Globus Medical, INC. | $230.93 | 2025 | Senza |
| Amgen INC. | $212.87 | 2019-2024 | Prolia, Evenity |
| Biodelivery Sciences International, INC. | $155.33 | 2019-2021 | |
| Grt US Holding, INC. | $147.29 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $132.99 | 2019-2024 | Trintellix |
| Abbvie INC. | $130.90 | 2021-2025 | Ubrelvy, Qulipta |
| Abbott Laboratories | $125.49 | 2019-2025 | Eterna, Proclaim |
| Forte Bio-Pharma LLC | $119.56 | 2020-2024 | Prolate, Nalocet |
| Ethicon INC. | $117.89 | 2021 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.